Clinical Trial Update: GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a GPC3-targeting CART cell therapy in advanced hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• GPC3-targeting CART Cell (GPC3-targeting chimeric antigen receptor T cell)

Snippet

Sponsor: jianming xu | Conditions: Advanced Hepatocellular Carcinoma | Phase 1 | Status: TERMINATED